News
British pharmaceutical company GSK(GSK) to acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, for as much as $2 ...
Honor has officially rolled out the Android 16 Beta 3 Developer Preview for its latest flagship, the Magic 7 Pro, making it one of the first non-Google phones globally to offer access to the ...
With its purchase of Boston Pharmaceuticals' drug, GSK extends a streak of dealmaking it's undertaken to build a liver ...
GSK PLC on Thursday gave an update on its investigational targeted inhibitor linerixibat as a treatment for relentless itch. The London-based pharmaceutical company said in a phase 3 trial ...
Apple has released iOS 18.5 Beta 3, marking a significant step forward in its software development process. This update, tailored for developers and beta testers, focuses on enhancing system ...
In Dark Winds season 3 episode 7, titled T’áá Álts’íísígo or Just a Small Piece, multiple threads converge as the penultimate chapter delivers major revelations. Joe Leaphorn ...
GSK has news on that front today, as well, reporting that the phase 2/3 COSTAR trial of Jemperli with experimental TIM-3 antagonist cobolimab will move into the phase 3 stage on the advice of its ...
Apple today seeded the third beta of an upcoming macOS Sequoia 15.5 update to developers for testing purposes, with the software coming a week after Apple released the second macOS Sequoia ...
The recent closed beta leaks coming from credible sources like Sleep hint at multiple new Echo skins heading to version 2.3. It seems Phantom Crownless, along with other Tacet Discord skins ...
The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results